Buscar
Mostrando ítems 11-20 de 937
Methicillin-susceptible, vancomycin-resistant staphylococcus aureus, Brazil
(Centers for Disease Control and Prevention, 2015)
We report characterization of a methicillin-susceptible, vancomycin-resistant bloodstream isolate of Staphylococcus aureus recovered from a patient in Brazil. Emergence of vancomycin resistance in methicillin-susceptible ...
Methicillin-susceptible, vancomycin-resistant staphylococcus aureus, Brazil
(Centers for Disease Control and Prevention, 2015)
We report characterization of a methicillin-susceptible, vancomycin-resistant bloodstream isolate of Staphylococcus aureus recovered from a patient in Brazil. Emergence of vancomycin resistance in methicillin-susceptible ...
Vancomycin-induced thrombocytopenia: a rare adverse effect in a patient submitted to bone graft in the jaw
(2017-01-01)
Introduction: Thrombocytopenia is the reduction in the number of blood platelets, which may be caused by several different conditions such as sepsis, disseminated intravascular clotting, and large blood losses. Additionally, ...
First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil
(Amer Soc Microbiology, 2014)
In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus
(Elsevier B.V., 2008-04-01)
Omiganan, a novel topical cationic peptide active against a broad spectrum of bacteria and yeast, is targeted for the prevention of catheter-associated infections. the spectrum of this agent was evaluated against contemporary ...
Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterization
(Elsevier B.V., 2003-02-01)
We report a case of infective endocarditis due to vancomycin-intermediate Staphylococcus aureus (VISA) that did not respond to high doses of vancomycin. Initial vancomycin MIC of the last isolate recovered from blood was ...
Study on the susceptibility of Enterococcus faecalis from infectious processes to ciprofloxacin and vancomycin
(Centro de Estudos de Venenos e Animais Peçonhentos, 2005-09)
Enterococcus faecalis is considered a pathogen responsible for hospital infections and, due to its frequent multi-resistant profile, has caused preoccupations among many medical authorities. The objective of this study was ...
Vancomycin-resistant enterococcus outbreak in a pediatric intensive care unit: report of successful interventions for control and prevention
(ASSOC BRAS DIVULG CIENTIFICASAO PAULO, 2012)
The objective of this study is to retrospectively report the results of interventions for controlling a vancomycin-resistant enterococcus (VRE) outbreak in a tertiary-care pediatric intensive care unit (PICU) of a University ...
Enterococcal endocarditis: can we win the war?
(Springer, 2012)
Treatment of enterococcal infections has long been recognized as an important clinical challenge, particularly in the setting of infective endocarditis (IE). Furthermore, the increase prevalence of isolates exhibiting ...